News
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
Print Subscription
eNewsletter

logo
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Specialty
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
OncClub
All Oncology News
Pipeline Report
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conference Coverage
Conference Listing
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Interactive Tools
Learning Modules
Presentations
Sponsored
Print Subscription
eNewsletter
Advertisement
Urothelial Cancer
| Breast Cancer
| Lung Cancer
| Gastrointestinal Cancer
| Genitourinary Cancers
| Ovarian Cancer
| Prostate Cancer
| Melanoma & Skin Cancer
| Mantle Cell Lymphoma
| Myeloproliferative Neoplasms
| Biosimilars
| Brain Cancer
| Business Management
| CAR T-cell Therapy
| COVID-19
| Chronic Lymphocytic Leukemia
| Colorectal Cancer
| Disparities in Cancer Care
| Global Oncology
| Gynecologic Oncology
| Head & Neck Cancers
| Hematologic Oncology
| Immuno-Oncology
| Multiple Myeloma
| Neoadjuvant HER2+
| Non-Hodgkin Lymphoma
| Oncology Nursing News
| Pediatric Oncology
| Precision Medicine in Oncology®
| Sarcomas/TGCT
| Supportive Care
View All >>
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
  • Business Management
  • CAR T-cell Therapy
  • COVID-19
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Global Oncology
  • Gynecologic Oncology
  • Head & Neck Cancers
  • Hematologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Mantle Cell Lymphoma
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Neoadjuvant HER2+
  • Non-Hodgkin Lymphoma
  • Oncology Nursing News
  • Ovarian Cancer
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Prostate Cancer
  • Sarcomas/TGCT
  • Supportive Care
  • Urothelial Cancer

SPOTLIGHT -

OncClub: Join the Chat on Trending Trials in Cancer
| In-person and virtual events just for HCPs

Unmet Needs in the Treatment of Lung Cancer

home / peer-exchange / nsclc-needs
Introduction: Exploration of Nab-Paclitaxel in NSCLC

EP. 1: Introduction: Exploration of Nab-Paclitaxel in NSCLC

July 16th 2014
Nab-Paclitaxel in Non-Small Cell Lung Cancer

EP. 2: Nab-Paclitaxel in Non-Small Cell Lung Cancer

July 16th 2014
Maintenance Nab-Paclitaxel in Squamous NSCLC

EP. 3: Maintenance Nab-Paclitaxel in Squamous NSCLC

July 16th 2014
Subgroup Analyses for Nab-Paclitaxel in NSCLC

EP. 4: Subgroup Analyses for Nab-Paclitaxel in NSCLC

July 16th 2014
Next-Generation EGFR Inhibitors in NSCLC

EP. 5: Next-Generation EGFR Inhibitors in NSCLC

July 16th 2014
AZD9291 and Rociletinib in T790M-Mutant NSCLC

EP. 6: AZD9291 and Rociletinib in T790M-Mutant NSCLC

July 16th 2014
Afatinib Plus Cetuximab in Resistant NSCLC

EP. 7: Afatinib Plus Cetuximab in Resistant NSCLC

July 16th 2014
Frontline ALK, EGFR Inhibition in NSCLC

EP. 8: Frontline ALK, EGFR Inhibition in NSCLC

July 16th 2014
Next-Generation ALK Inhibitors in NSCLC

EP. 9: Next-Generation ALK Inhibitors in NSCLC

July 16th 2014
Utilizing Next-Generation ALK Inhibitors in NSCLC

EP. 10: Utilizing Next-Generation ALK Inhibitors in NSCLC

July 16th 2014
Efficacy of Next-Generation ALK Inhibitors

EP. 11: Efficacy of Next-Generation ALK Inhibitors

July 16th 2014
PD-1 Inhibition in Lung Cancer

EP. 12: PD-1 Inhibition in Lung Cancer

July 16th 2014
Nivolumab in Non-Small Cell Lung Cancer

EP. 13: Nivolumab in Non-Small Cell Lung Cancer

July 16th 2014
Multiple PD-1/PD-L1 Agents in Lung Cancer

EP. 14: Multiple PD-1/PD-L1 Agents in Lung Cancer

July 16th 2014
PD-1/PD-L1 Inhibitors Across NSCLC Treatment Settings

EP. 15: PD-1/PD-L1 Inhibitors Across NSCLC Treatment Settings

July 16th 2014
Role of Maintenance Therapy in NSCLC

EP. 16: Role of Maintenance Therapy in NSCLC

July 16th 2014
Maintenance Therapy Clinical Trials for NSCLC

EP. 17: Maintenance Therapy Clinical Trials for NSCLC

July 16th 2014
PointBreak and AVAPERL Studies in NSCLC

EP. 18: PointBreak and AVAPERL Studies in NSCLC

July 16th 2014
Emerging Therapies in Non-Small Cell Lung Cancer

EP. 19: Emerging Therapies in Non-Small Cell Lung Cancer

July 16th 2014
Novel Angiogenesis Inhibitors in NSCLC

EP. 20: Novel Angiogenesis Inhibitors in NSCLC

July 16th 2014
Potential New Biomarkers in Lung Cancer

EP. 21: Potential New Biomarkers in Lung Cancer

July 16th 2014
Conclusion: Addressing Unmet Needs in Lung Cancer

EP. 22: Conclusion: Addressing Unmet Needs in Lung Cancer

July 16th 2014

Latest Conference Coverage

Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors

Navigating Systemic Therapy for RCC: Balancing Risk Status and Response

ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC

Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact